Unlocking Progress in Headache and Sleep Clinical Research in a Q&A with Dr. Sonia QuintasÂ
Medpace is proud to welcome Dr. Sonia Quintas, an accomplished and board-certified Neurologist, to our medical leadership team. Dr. Quintas brings nearly a decade of...
Inside the Lab: Q&A with Katie Rinderknecht, Executive Director of Laboratory Services
Katie Rinderknecht, MHA, Executive Director of Laboratory Services, discusses her career journey and how Medpace continues to evolve its central lab operations to better support…
[On-Demand Webinar] Advancing Atherosclerotic Cardiovascular Disease Trials Through Innovative Imaging Endpoints
As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating...
JSMO 2025 HighlightsÂ
As biopharmaceutical companies seek to optimize clinical trial design, accelerate regulatory approvals, and improve patient outcomes, insights from JSMO 2025 provide a critical foundation for…
Medpace Central Labs Expand Singapore Facility
As part of our continuous effort to enhance our laboratory capabilities and better serve our Sponsors, Medpace is proud to announce the expansion of our…
Chronic Kidney Disease & Its Impact on Clinical Development – Part 2
This post is the second of a three-part blog series. In Part 2, we take a look at the biomarkers for chronic kidney disease.
Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers
We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…
Belgium Central Lab Expansion
As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
The Current Biomarker Landscape in Immuno-Oncology
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.